查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924715

非穿戴式剂量测定市场按技术、辐射类型、应用、最终用户和分销管道划分－2026-2032年全球预测

Non-wearable Dosimetry Market by Technology, Radiation Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年非穿戴式剂量测定市值为 2.0475 亿美元，预计到 2026 年将成长至 2.2536 亿美元，年复合成长率为 9.18%，到 2032 年将达到 3.7868 亿美元。

关键市场统计数据
基准年 2025 2.0475亿美元
预计年份：2026年 2.2536亿美元
预测年份 2032 3.7868亿美元
复合年增长率 (%) 9.18%

本文简要概述了非穿戴式剂量测定设备在营运和监管方面的重要性，以及影响其采购和实施的不断变化的期望。

非穿戴式剂量测定技术在辐射防护、环境监测和工业安全领域中占有重要的地位。用于监测环境或区域辐射水平的设备和系统，包括固定式检测器以及可部署的被动式和主动式感测器，是职业安全计画、环境监测和监管合规机制的基础组成部分。从医院到核能设施，相关人员都依赖可靠且经过认证的测量解决方案来保障员工安全和公众健康。

数位化融合、检测器材料的进步以及监管趋同正在从根本上重塑产品设计、服务模式和采购政策。

非穿戴式剂量测定领域正经历变革性的转变，这主要得益于数位整合、材料创新以及日益严格的监管。数位化正在从基本数据记录发展到连网检测器，并具备远端监控、边缘分析和自动警报功能，使设施操作人员能够快速且准确地应对异常情况。检测器材料和讯号处理技术的进步提高了灵敏度并延长了使用寿命，而小型化和加固化则拓展了在严苛工业环境中的安装选择。

新关税对供应链韧性、筹资策略和製造决策的连锁反应，正在促使产业优先事项和伙伴关係关係进行重塑。

2025年推出的关税和贸易措施为非穿戴式剂量测定设备的供应链和采购决策带来了新的复杂性。关键零件和成品的关税提高了采购风险的可见度，促使许多企业重新评估供应商关係和总到岸成本，而不仅仅关注单位成本。随着采购团队考虑各种替代方案，在可行的情况下，回流和近岸外包方案正受到越来越多的关注，製造商也在考虑区域组装和零件采购，以降低关税风险并缩短前置作业时间。

多维細項分析揭示了技术选择、应用需求、最终用户画像、辐射类型和分销管道如何驱动采购和部署趋势

透过了解技术、应用、最终用户、辐射类型和分销管道等方面的细分，可以多维度地了解需求驱动因素和供应商定位。从技术角度来看，市场可分为主动式和被动式系统。主动式系统主要由电子剂量计组成，可实现即时监测和网路警报；而被动式系统则包括胶片剂量计、OSL 和 TLD 等，这些系统具有成熟可靠、维护成本低的记录方式，是需要长期剂量累积时的首选。每种技术方案都面临独特的校准、维护和资料处理挑战，这些挑战会影响整体拥有成本以及不同运行环境的适用性。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和监管重点将影响非穿戴式剂量测定技术的应用模式、服务需求和供应链策略。

区域趋势在非穿戴式剂量测定设备的采用模式、法规要求和供应链配置中发挥关键作用。在美洲，成熟的医疗保健基础设施、工业安全计画和环境监测措施共同影响着市场需求，从而对历史悠久的被动式系统和日益数位化化的主动式监测解决方案都产生了稳定的需求。法规结构强调可追溯性和校准合规性，这推动了对提供本地服务网路和快速回应技术支援的供应商的需求。

透过技术可靠性、全生命週期服务、通路伙伴关係和策略联盟，确保设备性能和客户连续性，从而获得竞争优势。

非穿戴式剂量计市场的竞争趋势主要集中在企业能否将卓越的技术、可靠的服务交付和完善的品管系统结合。主要企业透过持续投资于检测器精度、校准服务以及支援集中监测和资料存檔的软体平台来脱颖而出。能够提供从安装、校准到韧体维护和符合审核要求的报告等全生命週期支援的企业，正赢得安全关键型终端用户的更多信任。

领导企业增强供应链韧性、拓展服务主导产品以及调整产品架构以适应不断变化的监管和营运需求的实用策略

为了应对当前复杂的市场环境并获取策略价值，产业领导者应采取协调一致的营运、商业和技术策略。优先考虑价值链多元化和情境规划，以降低关税引发的供应中断风险，并确保关键零件的持续供应。同时，透过灵活的製造策略（例如区域组装和策略供应商合作）来增强采购韧性，从而缩短前置作业时间并提供本地化的售后服务。

采用系统性透明的调查方法，结合相关人员访谈、标准分析和三角验证综合分析，得出对市场动态的检验评估。

本执行摘要的研究结合了定性和定量方法，以深入了解市场动态。主要研究包括对各类相关人员进行结构化访谈，这些利害关係人包括采购人员、辐射安全负责人、技术服务提供者、仪器工程师和监管专家。这些访谈提供了关于操作要求、决策标准以及安装、校准和维护方面的实际考虑因素的第一手观点。

综合分析结果凸显了整合技术和服务产品、供应链韧性以及合规性为何决定着市场成功。

总之，非穿戴式剂量学领域正处于一个转折点，其特点是技术融合、供应链重组以及日益严格的监管要求。包括环境监测、医疗保健、工业安全和核能营运在内的各个领域的组织都在优先部署能够提供精确测量、审核记录和可靠服务支援的系统。主动电子监测与成熟的被动记录方法相结合，为众多终端用户提供了一条可行的途径，以平衡即时可见性需求和长期剂量记录要求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 非穿戴式剂量测定市场（依技术划分）

  • 活动类型
  • 被动的
    • 电影徽章
    • OSL
    • TLD

9. 非穿戴式剂量测定市场（依辐射类型划分）

  • β射线
  • 中子
  • X射线和伽玛射线

第十章 非穿戴式剂量测定市场（依应用划分）

  • 环境
  • 工业的
  • 医疗保健
  • 核能发电

第十一章 非穿戴式剂量测定市场（依最终用户划分）

  • 诊断中心
  • 医院
  • 工业安全
  • 核能发电厂
  • 研究所

第十二章 非穿戴式剂量测定市场（依分销通路划分）

  • 离线
  • 在线的

13. 按地区分類的非穿戴式剂量测定市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 非穿戴式剂量测定市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国非穿戴式剂量测定市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国非穿戴式剂量测定市场

第十七章：中国非穿戴式剂量测定市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AMETEK, Inc.
  • ATOMTEX Co., Ltd.
  • Bar-Ray Products, Inc.
  • Berkeley Nucleonics Corp.
  • Blackline Safety Corp.
  • Electronic & Engineering Co. P. Ltd.
  • Fuji Electric Co., Ltd.
  • General Atomics
  • Honeywell Automation India Ltd.
  • IBA Dosimetry GmbH
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Mirion Technologies, Inc.
  • Narda Safety Test Solutions GmbH
  • Nucleonix Systems Private Limited
  • PLA Electro Appliances Private Limited
  • PTW Freiburg GmbH
  • Saint-Gobain SA
  • Senergy Intellution Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-7A380DA7C448

The Non-wearable Dosimetry Market was valued at USD 204.75 million in 2025 and is projected to grow to USD 225.36 million in 2026, with a CAGR of 9.18%, reaching USD 378.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 204.75 million
Estimated Year [2026] USD 225.36 million
Forecast Year [2032] USD 378.68 million
CAGR (%) 9.18%

A concise framing of the operational and regulatory importance of non-wearable dosimetry devices and the evolving expectations shaping procurement and deployment

Non-wearable dosimetry occupies a critical niche at the intersection of radiation protection, environmental monitoring, and industrial safety. Devices and systems that monitor ambient or area radiation levels, including fixed detectors and deployable passive or active sensors, serve as foundational elements for occupational safety programs, environmental surveillance, and regulatory compliance regimes. Stakeholders from hospitals to nuclear facilities depend on reliable, certified measurement solutions to ensure worker safety and protect public health.

Recent years have seen elevated attention on instrumentation accuracy, lifecycle support, and data integrity as regulators and customers demand traceable records and auditable monitoring practices. Concurrently, advances in electronics, materials science, and data analytics are reshaping how area dosimetry is deployed and managed, creating new expectations for interoperability, remote diagnostics, and predictive maintenance. Supply chain resilience and manufacturing footprint considerations now factor heavily into procurement decisions as organizations seek continuity in critical safety infrastructure.

This introduction establishes the operational context for non-wearable dosimetry and frames the subsequent sections, which examine technological transitions, tariff-driven supply chain impacts, segmentation nuances, regional patterns, competitive dynamics, and pragmatic recommendations for leaders navigating an increasingly complex landscape.

How digital integration, detector material advances, and regulatory convergence are fundamentally reshaping product design, service models, and procurement preferences

The landscape of non-wearable dosimetry is undergoing transformative shifts driven by digital integration, materials innovation, and heightened regulatory rigor. Digitalization has moved beyond basic data logging to include networked detectors that support remote monitoring, edge analytics, and automated alerting, enabling facility operators to act on anomalies with speed and precision. Advances in detector materials and signal processing have improved sensitivity and extended operational lifetimes, while miniaturization and ruggedization have expanded deployment options in harsh industrial environments.

At the same time, regulatory frameworks and accreditation expectations are converging on clearer traceability, standardized calibration protocols, and requirements for long-term data retention. These pressures are incentivizing vendors to deliver not only hardware but integrated software services and lifecycle management solutions that include calibration, firmware updates, and documentation support. The emergence of cloud-hosted data solutions and secure telemetry has enabled centralized monitoring across distributed sites, but it has also raised cybersecurity and data governance considerations that organizations must address.

Transitioning to these new capabilities requires coordinated investments in interoperability, workforce training, and procurement strategies that favor modular, service-oriented offerings. As stakeholders prioritize systems that reduce operational friction and provide auditable records, vendors who pair technical performance with robust service models will gain preference in procurement conversations.

The ripple effects of new tariffs on supply chain resilience, procurement strategies, and manufacturing decisions that are reshaping industry priorities and partnerships

The introduction of tariffs and trade measures in 2025 has created a new layer of complexity for non-wearable dosimetry supply chains and procurement decisions. Tariffs on key components and finished instruments have amplified the visibility of sourcing risk, prompting many organizations to reassess supplier relationships and total landed cost rather than focusing solely on unit price. As procurement teams evaluate alternatives, reshoring and nearshoring options have gained traction where feasible, with manufacturers considering regional assembly or component sourcing to mitigate tariff exposure and shorten lead times.

At the buyer level, increased cost volatility has elevated the importance of contract flexibility and inventory management strategies. Long-term maintenance agreements and multi-year calibration contracts are being structured to protect service continuity and cost predictability. For vendors, tariffs have shifted competitive dynamics: those able to adapt manufacturing footprints, consolidate component suppliers, or re-platform products to use locally sourced parts are better positioned to preserve margins and customer relationships.

Additionally, the tariff environment has underscored the value of transparency across the supply chain. Buyers are demanding clearer provenance data and more rigorous supplier audits, while risk-aware organizations are prioritizing partners with diversified sourcing and robust contingency plans. Ultimately, tariffs are accelerating strategic shifts that emphasize resilience, supplier partnerships, and operational agility across the ecosystem.

Multidimensional segmentation insights revealing how technology choices, application needs, end-user profiles, radiation types, and distribution channels drive procurement and deployment dynamics

Understanding segmentation across technology, application, end user, radiation type, and distribution channel provides a multidimensional view of demand drivers and supplier positioning. Based on technology, the market is observed across active and passive systems; active systems are primarily composed of electronic dosimeters that enable real-time monitoring and networked alerts, while passive options include film badge, OSL, and TLD formats that offer proven, low-maintenance archival records and are favored where long-term dose integration is required. Each technology path has distinct calibration, maintenance, and data-handling implications that influence total cost of ownership and suitability for different operating environments.

Based on application, deployments cluster in environmental surveillance, industrial monitoring, medical imaging and therapy environments, and nuclear power operations, with each application imposing unique accuracy, response time, and certification demands. Based on end user, typical buyers include diagnostic centers, hospitals, industrial safety teams, nuclear power plants, and research laboratories; procurement decisions in these settings are shaped by organizational risk tolerance, regulatory exposure, and existing service ecosystems. Based on radiation type, detectors are optimized for beta, neutron, or X ray and gamma exposures, with sensor selection and calibration protocols tailored to the energy spectrum and expected dose profiles of the operating environment. Based on distribution channel, supply pathways include direct sales, distributor networks, and online channels, each offering differing degrees of technical support, logistics capability, and aftermarket service.

Taken together, these segmentation dimensions reveal that successful market engagement requires aligning product capability and commercial model to the specific technical requirements and procurement practices of each buyer cohort, and that cross-segmentation strategies-such as combining electronic monitoring with passive archival options-can address complex operational needs while opening new revenue and service opportunities.

Regional dynamics and regulatory priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption patterns, service needs, and supply chain strategies

Regional dynamics play a pivotal role in adoption patterns, regulatory expectations, and supply chain configurations for non-wearable dosimetry. In the Americas, demand is influenced by a mixture of mature healthcare infrastructure, industrial safety programs, and environmental monitoring initiatives, creating steady requirements for both long-established passive systems and increasingly digital active monitoring solutions. Regulatory frameworks emphasize traceability and calibration compliance, which in turn drives demand for vendors offering local service footprints and rapid technical support.

In Europe, Middle East & Africa, regulatory harmonization across jurisdictions and a strong focus on nuclear safety and medical device conformity shape procurement choices, while market diversity requires adaptable distribution strategies and multilingual technical support. In particular, regions with expanding nuclear or industrial sectors present opportunities for integrated surveillance systems that combine fixed detectors and centralized data platforms. The Asia-Pacific region exhibits a broad spectrum of demand dynamics, from advanced research and healthcare facilities in some markets to rapidly industrializing economies in others, which fuels a wide range of requirements from high-precision instruments to cost-effective archival solutions. Manufacturing hubs and component suppliers in the region also influence global supply chains, making Asia-Pacific central to sourcing and production strategies.

Across all regions, the combination of regulatory scrutiny, infrastructure investment, and local service capabilities determines how quickly new technologies are adopted and which commercial models succeed in the market.

Competitive advantage driven by technical reliability, lifecycle services, channel partnerships, and strategic alliances that ensure instrument performance and customer continuity

Competitive dynamics in the non-wearable dosimetry market center on the ability of companies to combine technical excellence with dependable service offerings and robust quality systems. Leading providers differentiate through sustained investment in detector accuracy, calibration services, and software platforms that enable centralized monitoring and data archival. Companies that can demonstrate end-to-end lifecycle support - from installation and calibration to firmware maintenance and audit-ready reporting - earn higher levels of trust among safety-critical end users.

Strategic partnerships and channel strategies are also important differentiators. Firms that cultivate deep relationships with distributors and service partners expand geographic reach and ensure continuity of after-sales support. In parallel, organizations that invest in training and certification programs for customers and resellers strengthen their value proposition and reduce implementation friction. Intellectual property in sensor design, signal processing algorithms, and calibration methodologies helps protect competitive advantage, but practical market leadership often flows from reliability in delivery and responsiveness in customer support.

Mergers, targeted acquisitions, and alliance building are recurring themes as companies seek to fill capability gaps, add regional service footprints, or accelerate software and data analytics offerings. Ultimately, the market rewards those who balance technical credibility with accessible service models and demonstrable operational continuity.

Action oriented strategies for leaders to bolster supply chain resilience, expand service led offerings, and align product architectures with evolving regulatory and operational needs

To navigate current complexities and capture strategic value, industry leaders should pursue a coordinated set of operational, commercial, and technical actions. Prioritize supply chain diversification and scenario planning to reduce exposure to tariff-driven disruption and to maintain continuity of critical components. Complement sourcing resilience with flexible manufacturing strategies, including regional assembly or strategic supplier partnerships, to contain lead times and support localized after-sales service.

Invest in modular product architectures that enable seamless integration of electronic monitoring systems with passive archival detectors, thereby offering customers flexible solutions that meet both real-time alerting and long-term compliance needs. Strengthen service portfolios by bundling calibration, training, and remote monitoring as subscription offerings that create predictable revenue streams and deepen customer relationships. Emphasize interoperability and open data standards to facilitate integration into facility management and regulatory reporting workflows, while instituting robust cybersecurity and data governance practices.

Engage proactively with regulators and industry consortia to shape emerging standards and to ensure that new product innovations meet certification pathways efficiently. Finally, upskill field service teams and customer support functions to deliver consultative implementation assistance, because operational reliability and rapid responsiveness remain the decisive factors for end users when selecting a vendor.

A methodical and transparent research approach combining stakeholder interviews, standards analysis, and triangulated synthesis to produce a validated assessment of market dynamics

The research underpinning this executive summary combines qualitative and quantitative approaches to produce a validated view of market dynamics. Primary research included structured interviews with a cross-section of stakeholders: procurement leaders, radiation safety officers, technical service providers, instrumentation engineers, and regulatory specialists. These interviews provided firsthand perspectives on operational requirements, decision criteria, and practical considerations around installation, calibration, and maintenance.

Secondary research drew on publicly available regulatory documents, standards publications, technical white papers, and manufacturer product literature to map technology capabilities, certification expectations, and historical performance characteristics. Data and insights were triangulated through cross-validation between primary inputs and authoritative secondary sources to ensure consistency and to identify contrasting viewpoints. Segmentation logic was developed by mapping technology attributes against application use cases and end-user procurement behavior, while regional analysis incorporated policy drivers and infrastructure considerations.

Methodological rigor was applied through iterative review cycles with subject-matter experts and by documenting assumptions and limitations inherent in qualitative synthesis. The goal was to deliver a transparent, reproducible assessment that supports confident decision-making while acknowledging areas where ongoing monitoring or supplemental primary research would reduce residual uncertainty.

Consolidated findings emphasizing why integrated technology-service offerings, supply chain resilience, and regulatory alignment will define success in the market

In conclusion, the non-wearable dosimetry landscape is at an inflection point defined by technological convergence, supply chain realignment, and intensifying regulatory expectations. Organizations across environmental monitoring, healthcare, industrial safety, and nuclear operations are prioritizing systems that deliver accurate measurements, auditable records, and dependable service support. The interplay of active electronic monitoring and established passive archival methods offers a pragmatic path for many end users to reconcile demands for real-time awareness with requirements for long-term dose documentation.

Tariff pressures have foregrounded supply chain resilience and total cost considerations, prompting both buyers and sellers to rethink sourcing, manufacturing footprints, and contractual structures. Regionally differentiated adoption patterns underscore the importance of local service presence and regulatory alignment, while competitive advantages accrue to companies that combine technical rigor with lifecycle service models. For decision-makers, the pragmatic priorities are clear: invest in interoperability and data governance, secure diversified supply options, and align commercial models to support predictable maintenance and compliance.

These themes point toward a market that will favor flexible, service-oriented offerings and partners capable of delivering operational continuity. For stakeholders preparing procurement or investment strategies, focusing on these areas will improve readiness and reduce exposure to the key risks identified across the analysis.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-wearable Dosimetry Market, by Technology

  • 8.1. Active
  • 8.2. Passive
    • 8.2.1. Film Badge
    • 8.2.2. Osl
    • 8.2.3. Tld

9. Non-wearable Dosimetry Market, by Radiation Type

  • 9.1. Beta
  • 9.2. Neutron
  • 9.3. X Ray & Gamma

10. Non-wearable Dosimetry Market, by Application

  • 10.1. Environmental
  • 10.2. Industrial
  • 10.3. Medical
  • 10.4. Nuclear Power

11. Non-wearable Dosimetry Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Industrial Safety
  • 11.4. Nuclear Power Plants
  • 11.5. Research Laboratories

12. Non-wearable Dosimetry Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Non-wearable Dosimetry Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Non-wearable Dosimetry Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-wearable Dosimetry Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Non-wearable Dosimetry Market

17. China Non-wearable Dosimetry Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AMETEK, Inc.
  • 18.6. ATOMTEX Co., Ltd.
  • 18.7. Bar-Ray Products, Inc.
  • 18.8. Berkeley Nucleonics Corp.
  • 18.9. Blackline Safety Corp.
  • 18.10. Electronic & Engineering Co. P. Ltd.
  • 18.11. Fuji Electric Co., Ltd.
  • 18.12. General Atomics
  • 18.13. Honeywell Automation India Ltd.
  • 18.14. IBA Dosimetry GmbH
  • 18.15. Landauer, Inc.
  • 18.16. Ludlum Measurements, Inc.
  • 18.17. Mirion Technologies, Inc.
  • 18.18. Narda Safety Test Solutions GmbH
  • 18.19. Nucleonix Systems Private Limited
  • 18.20. PLA Electro Appliances Private Limited
  • 18.21. PTW Freiburg GmbH
  • 18.22. Saint-Gobain S.A.
  • 18.23. Senergy Intellution Pvt. Ltd.
  • 18.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-WEARABLE DOSIMETRY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-WEARABLE DOSIMETRY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY FILM BADGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OSL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY TLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY BETA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NEUTRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY X RAY & GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY INDUSTRIAL SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY NUCLEAR POWER PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NON-WEARABLE DOSIMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA NON-WEARABLE DOSIMETRY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)